Why the study?
Does levosimendan improve mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction?
Does levosimendan improve mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction?
Routine use of levosimendan in patients with cardiogenic shock complicating STEMI does not appear to impact short- or long-term mortality.
Answers are grounded in this paper and cite their sources.
Should not prompt routine levosimendan use in STEMI cardiogenic shock; leaves open confirmation via randomized trials.
BACKGROUND: The aim of this study was to evaluate the effect of levosimendan on mortality in cardiogenic shock (CS) after ST elevation myocardial infarction (STEMI). METHODS AND RESULTS: Data were obtained prospectively from the SCAAR (Swedish Coronary Angiography and Angioplasty Register) and the RIKS-HIA (Register of Information and Knowledge about Swedish Heart Intensive Care Admissions) about 94 consecutive patients with CS due to STEMI. Patients were classified into levosimendan-mandatory and levosimendan-contraindicated cohorts. Inotropic support with levosimendan was mandatory in all patients between January 2004 and December 2005 (n = 46). After the SURVIVE and REVIVE II studies were presented, levosimendan was considered contraindicated and was not used in consecutive patients between December 2005 and December 2006 (n = 48). The cohorts were similar with respect to pre-treatment characteristics and concomitant medications. There was no difference in the incidence of new-onset atrial fibrillation, in-hospital cardiac arrest and length of stay at the coronary care unit. There was no difference in adjusted mortality at 30 days and at one year. CONCLUSION: The use of levosimendan neither improves nor worsens mortality in patients with CS due to STEMI. Well-designed randomized clinical trials are needed to define the role of inotropic therapy in the treatment of CS.
No takes yet. Share an insight, caveat, or question.
Elmir Ömerovic (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: